Plasma thymidylate synthase and dihydrofolate reductase mRNA levels as potential predictive biomarkers of pemetrexed sensitivity in patients with advanced non-small cell lung cancer.

Li, Tao; Huang, Jin-Bo; Lu, Jun-Guo; Li, Rong; Wang, Yan; Shi, Xiang-Rong; Shi, Min-Xin; Zhang, Xiao-Dong

Li, Tao; Huang, Jin-Bo; Lu, Jun-Guo; Li, Rong; Wang, Yan; Shi, Xiang-Rong; Shi, Min-Xin; Zhang, Xiao-Dong.

Afiliación

Li T; Department of Medical Oncology, Nantong Tumor Hospital, Nantong, China.
Huang JB; Department of Respiratory Medicine, Affiliated Hospital of Nantong University, Nantong, China.
Lu JG; Department of Medical Oncology, Nantong Tumor Hospital, Nantong, China.
Li R; Department of Medical oncology, Affiliated Taikang Xianlin Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China.
Wang Y; Department of Medical Oncology, Nantong Tumor Hospital, Nantong, China.
Shi XR; Department of Medical Oncology, Nantong Tumor Hospital, Nantong, China.
Shi MX; Department of Thoracic Surgery, Nantong Tumor Hospital, Nantong, China.
Zhang XD; Department of Medical Oncology, Nantong Tumor Hospital, Nantong, China.

J Thorac Dis ; 12(12): 7313-7319, 2020 Dec.

Article en En | MEDLINE | ID: mdl-33447420

Palabras clave

Thymidylate synthase (TS); dihydrofolate reductase (DHFR); mRNA; non-small cell lung cancer (NSCLC)

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Thorac Dis Año: 2020 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google